NIP
ELV icon

Nicholas Investment Partners’s Elevance Health ELV Stock Holding History

Nicholas Investment Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-12,308
Closed -$1.62M – 305
2016
Q2 		$1.62M Buy
+12,308
New +$1.68M 0.11% 270

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Nicholas Investment Partners's ELV Position: Q3 2016 in Review

Nicholas Investment Partners sold out of Elevance Health (ELV) in Q3 2016, closing a stake of 12,308 shares — an estimated $1.62M sold.

Nicholas Investment Partners first reported a position in ELV in Q2 2016 and held it in 1 quarter. The position peaked at $1.62M in Q2 2016. 737 funds tracked by Wall St. Rank hold ELV as of Q3 2016.

  • Nicholas Investment Partners reported no remaining Elevance Health position as of Q3 2016 after selling out during the quarter.
  • Nicholas Investment Partners sold 12,308 Elevance Health shares in Q3 2016, an estimated $1.62M.
  • Nicholas Investment Partners first reported a position in Elevance Health in Q2 2016 and held it in 1 quarter.
  • Nicholas Investment Partners's Elevance Health position peaked at $1.62M in Q2 2016.
  • 737 funds tracked by Wall St. Rank held Elevance Health as of Q3 2016.

Based on Nicholas Investment Partners's 13F filing for Q3 2016, filed 14 Nov 2016.